{"hands_on_practices": [{"introduction": "Before a diagnostic test can be trusted in clinical practice, its fundamental performance must be quantified. This exercise grounds you in this essential first step by calculating sensitivity and specificity—the cornerstone metrics of diagnostic accuracy. Using data from a clinical validation scenario comparing a skin prick test to a gold-standard nasal provocation test [@problem_id:5063871], you will not only compute these values but also explore the critical trade-offs involved in selecting an optimal diagnostic threshold.", "problem": "A tertiary otorhinolaryngology clinic is validating the diagnostic performance of the Skin Prick Test (SPT) to birch pollen for patients with seasonal allergic rhinitis, using the Nasal Provocation Test (NPT) as the gold standard reference for clinically relevant nasal allergy. In a consecutive cohort, the following outcomes were observed when comparing SPT to NPT: true positives $42$, false positives $10$, true negatives $80$, and false negatives $18$. Using the foundational definitions of diagnostic sensitivity and specificity relative to a gold standard, compute the sensitivity and specificity of SPT for birch pollen in this cohort. Round both sensitivity and specificity to three significant figures and report them as decimals. Express your final numerical values as a row matrix in the order $\\text{sensitivity}$, $\\text{specificity}$.\n\nThen, building from first principles appropriate to clinical decision-making in otorhinolaryngology, discuss how an optimal SPT wheal diameter cutoff should be selected for identifying candidates for allergen immunotherapy, considering the trade-offs between false positives and false negatives, and the role of Receiver Operating Characteristic (ROC) analysis, likelihood ratios, prior probability, and expected loss. Do not perform additional calculations beyond deriving sensitivity and specificity; the discussion should be conceptual and principled.", "solution": "The problem requires a two-part response. First, the calculation of sensitivity and specificity for the Skin Prick Test (SPT) using the provided cohort data. Second, a conceptual discussion on the principles of selecting an optimal diagnostic cutoff.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- Test under evaluation: Skin Prick Test (SPT) for birch pollen.\n- Gold standard reference: Nasal Provocation Test (NPT).\n- True positives ($TP$): $42$.\n- False positives ($FP$): $10$.\n- True negatives ($TN$): $80$.\n- False negatives ($FN$): $18$.\n- Required rounding: three significant figures for both sensitivity and specificity.\n- Required output format: a row matrix of the form [sensitivity, specificity].\n- Required conceptual discussion topics: optimal SPT wheal diameter cutoff, trade-offs between false positives and false negatives, Receiver Operating Characteristic (ROC) analysis, likelihood ratios, prior probability, and expected loss.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem uses standard, well-established definitions and methodologies from clinical epidemiology and biostatistics to assess diagnostic test performance. The clinical context—comparing SPT to NPT for allergic rhinitis—is medically and scientifically sound. This is a routine type of analysis in medical research. The problem is valid.\n- **Well-Posed:** All necessary data ($TP$, $FP$, $TN$, $FN$) for the calculation are provided. The terms sensitivity and specificity have precise, universally accepted definitions. The task is clearly specified. The problem is valid.\n- **Objective:** The problem is stated using clear, objective, and standard terminology of diagnostic testing. It is free of ambiguity and subjective claims. The problem is valid.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A complete solution will be provided.\n\n### Part 1: Calculation of Sensitivity and Specificity\n\nThe performance of a diagnostic test is evaluated against a \"gold standard,\" which is assumed to represent the true state of the patient (disease present or absent). In this problem, the Nasal Provocation Test (NPT) is the gold standard.\n\nThe total number of patients with the condition (clinically relevant nasal allergy, as determined by NPT) is the sum of True Positives ($TP$) and False Negatives ($FN$).\n$$ \\text{Total with disease} = TP + FN $$\nThe total number of patients without the condition is the sum of True Negatives ($TN$) and False Positives ($FP$).\n$$ \\text{Total without disease} = TN + FP $$\n\n**Sensitivity** (also known as the True Positive Rate) is the proportion of individuals with the disease who are correctly identified by the test as having the disease.\n$$ \\text{Sensitivity} = \\frac{TP}{TP + FN} $$\nSubstituting the given values:\n$$ \\text{Sensitivity} = \\frac{42}{42 + 18} = \\frac{42}{60} = 0.7 $$\nRounding to three significant figures, we get $0.700$.\n\n**Specificity** (also known as the True Negative Rate) is the proportion of individuals without the disease who are correctly identified by the test as not having the disease.\n$$ \\text{Specificity} = \\frac{TN}{TN + FP} $$\nSubstituting the given values:\n$$ \\text{Specificity} = \\frac{80}{80 + 10} = \\frac{80}{90} = \\frac{8}{9} $$\nAs a decimal, this is $0.8888...$. Rounding to three significant figures gives $0.889$.\n\n### Part 2: Conceptual Discussion on Selecting an Optimal Cutoff\n\nThe result of an SPT, the wheal diameter, is a continuous variable. To use it as a dichotomous diagnostic test (positive/negative), a specific diameter cutoff must be chosen. The selection of this cutoff is a critical decision that involves balancing competing objectives.\n\n**Trade-offs between False Positives and False Negatives:** The choice of a cutoff value establishes a trade-off between sensitivity and specificity. A lower cutoff (e.g., a smaller wheal diameter is considered positive) increases the test's sensitivity, as it will correctly identify more allergic individuals ($TP$ increases). However, this comes at the cost of decreased specificity, as more non-allergic individuals will also test positive ($FP$ increases). Conversely, a higher cutoff increases specificity (fewer $FP$) but decreases sensitivity (more $FN$).\n\nThe optimal cutoff depends on the clinical context and the consequences of misclassification. When considering a patient for allergen immunotherapy, the costs of a false positive versus a false negative must be weighed.\n- A **False Positive** ($FP$) leads to a non-allergic patient being offered immunotherapy. The consequences include the financial cost of treatment, the time commitment, the inconvenience of regular injections, and the risk of systemic adverse reactions, which can be severe.\n- A **False Negative** ($FN$) leads to an allergic patient being denied a potentially effective treatment. The consequence is continued morbidity from allergic rhinitis, reduced quality of life, and potential for disease progression.\nThe optimal cutoff must balance the \"loss\" or \"cost\" associated with these two types of errors.\n\n**Receiver Operating Characteristic (ROC) Analysis:** An ROC curve is the primary tool for visualizing and selecting an optimal cutoff. It is a plot of the True Positive Rate (Sensitivity) on the y-axis against the False Positive Rate ($1 - \\text{Specificity}$) on the x-axis for all possible cutoff values. Each point on the curve represents a different cutoff and its associated sensitivity/specificity pair. A test with no diagnostic value follows the diagonal line of no-discrimination from ($0,0$) to ($1,1$). A perfect test would pass through the top-left corner ($0,1$), representing $100\\%$ sensitivity and $100\\%$ specificity. The Area Under the Curve (AUC) is a global measure of test performance, with $1.0$ being perfect and $0.5$ being no better than chance. The optimal cutoff is a specific point on this curve, often chosen to maximize Youden's J index ($\\text{Sensitivity} + \\text{Specificity} - 1$), which gives equal weight to both types of errors, or by identifying the point on the curve closest to the ideal ($0,1$) point.\n\n**Likelihood Ratios (LRs):** LRs quantify how much a positive or negative test result changes the probability of disease. They are defined as:\n- Positive Likelihood Ratio ($LR+$) = $\\frac{\\text{Sensitivity}}{1 - \\text{Specificity}}$\n- Negative Likelihood Ratio ($LR-$) = $\\frac{1 - \\text{Sensitivity}}{\\text{Specificity}}$\nUnlike sensitivity and specificity, LRs are less dependent on the prevalence of the disease. A different cutoff value generates a different pair of LRs. For confirming a diagnosis to initiate a significant treatment like immunotherapy, a clinician might desire a cutoff that yields a very high $LR+$ (e.g., $> 10$), which strongly rules in the disease. This generally corresponds to a high-specificity cutoff.\n\n**Prior Probability and Bayesian Updating:** The clinical utility of a test result depends not only on the test's characteristics (sensitivity, specificity) but also on the prior probability (or pre-test probability) of the disease in the patient being tested. This is the clinician's estimate of the chance the patient has the allergy *before* the test is done, based on history and symptoms. Bayes' Theorem formalizes how to update this probability: $\\text{Post-test odds} = \\text{Pre-test odds} \\times \\text{LR}$. The optimal cutoff may differ depending on the pre-test probability. In a high-risk population, a lower cutoff might be acceptable, whereas in a low-risk screening scenario, a higher cutoff would be needed to ensure a high positive predictive value and avoid an unacceptably large number of false positives.\n\n**Expected Loss (Decision Theory):** The most rigorous framework for selecting a cutoff is decision theory, which aims to minimize expected loss. This requires assigning a quantitative \"loss\" or \"cost\" to each of the four possible outcomes (TP, FP, TN, FN). For example, $L_{FP}$ is the cost of a false positive (unnecessary treatment, side effects) and $L_{FN}$ is the cost of a false negative (continued illness). The expected loss for a given cutoff $c$ is a function of the prevalence ($p$), the test's performance at that cutoff ($\\text{sens}(c)$, $\\text{spec}(c)$), and the assigned losses:\n$$ E[\\text{Loss}(c)] = p \\cdot (1-\\text{sens}(c)) \\cdot L_{FN} + (1-p) \\cdot (1-\\text{spec}(c)) \\cdot L_{FP} $$\n(assuming zero loss for correct decisions). The optimal cutoff, $c^*$, is the one that minimizes this expected loss function. This method explicitly incorporates the clinical values and consequences into the decision, providing the most tailored and rational basis for choosing the cutoff for a specific clinical task like selecting patients for immunotherapy.", "answer": "$$ \\boxed{\\begin{pmatrix} 0.700 & 0.889 \\end{pmatrix}} $$", "id": "5063871"}, {"introduction": "A test's intrinsic accuracy is only half the story; its true value lies in how it changes our assessment of a patient's condition. This practice moves from test evaluation to clinical application, demonstrating how to translate sensitivity and specificity into a more practical tool: the Likelihood Ratio. You will apply the odds form of Bayes’ theorem [@problem_id:5063919] to see precisely how a positive or negative test result modifies a pre-test probability, a fundamental skill for evidence-based decision-making.", "problem": "An otorhinolaryngology clinic evaluates patients with suspected immunoglobulin E-mediated allergic rhinitis using the Skin Prick Test (SPT). For a specific aeroallergen, the SPT has sensitivity $0.88$ and specificity $0.82$ when referenced to a validated gold-standard diagnosis. A patient presents with a clinical pre-test probability $0.40$ for true sensitization to this allergen based on history, seasonality, and local exposure.\n\nUsing only foundational definitions and the odds form of Bayes’ theorem, proceed as follows:\n- Define sensitivity as $P(T^{+}\\mid D^{+})$ and specificity as $P(T^{-}\\mid D^{-})$, where $T^{+}$/$T^{-}$ denote positive/negative test results and $D^{+}$/$D^{-}$ denote presence/absence of true disease (sensitization).\n- From these definitions, derive expressions for the positive Likelihood Ratio (LR) $(LR^{+})$ and the negative Likelihood Ratio (LR) $(LR^{-})$ in terms of sensitivity and specificity.\n- Convert the pre-test probability $0.40$ into pre-test odds using the definition $\\text{odds} = \\frac{p}{1-p}$, then apply odds multiplication with $LR^{+}$ to obtain the post-test odds for a positive SPT, and with $LR^{-}$ to obtain the post-test odds for a negative SPT.\n- Convert each post-test odds back into a post-test probability via $p = \\frac{\\text{odds}}{1+\\text{odds}}$.\n\nCompute and report, in this order, the numerical values of $LR^{+}$, $LR^{-}$, the post-test probability after a positive SPT, and the post-test probability after a negative SPT. Round all reported quantities to four significant figures. Express all probabilities as decimals (not as percentages). No units are required in the final numerical answers.", "solution": "The problem statement has been critically validated and is deemed sound. It is scientifically grounded in the principles of medical statistics and epidemiology, is well-posed with all necessary information provided, and is expressed in objective, formal language. We may therefore proceed with a complete solution.\n\nThe problem requires the calculation of likelihood ratios and post-test probabilities for a diagnostic test, given its performance characteristics and a patient's pre-test probability of disease. We will follow the prescribed steps using the provided definitions.\n\nLet $D^{+}$ denote the presence of true sensitization (disease) and $D^{-}$ denote its absence.\nLet $T^{+}$ denote a positive Skin Prick Test (SPT) result and $T^{-}$ denote a negative result.\n\nThe given parameters are:\n-   Pre-test probability of sensitization: $P(D^{+}) = 0.40$.\n-   Sensitivity of the SPT: $S_e = P(T^{+}\\mid D^{+}) = 0.88$.\n-   Specificity of the SPT: $S_p = P(T^{-}\\mid D^{-}) = 0.82$.\n\nFirst, we derive the expressions for the positive and negative Likelihood Ratios ($LR^{+}$ and $LR^{-}$).\n\nThe positive Likelihood Ratio ($LR^{+}$) is the ratio of the probability of a positive test result in a patient with the disease to the probability of a positive test result in a patient without the disease.\n$$LR^{+} = \\frac{P(T^{+}\\mid D^{+})}{P(T^{+}\\mid D^{-})}$$\nThe numerator is the sensitivity, $S_e$. The denominator, $P(T^{+}\\mid D^{-})$, is the probability of a false positive. Since a patient without the disease can only test positive or negative, we have $P(T^{+}\\mid D^{-}) + P(T^{-}\\mid D^{-}) = 1$. The term $P(T^{-}\\mid D^{-})$ is the specificity, $S_p$. Therefore, $P(T^{+}\\mid D^{-}) = 1 - S_p$.\nSubstituting these into the expression for $LR^{+}$ yields:\n$$LR^{+} = \\frac{S_e}{1 - S_p}$$\n\nThe negative Likelihood Ratio ($LR^{-}$) is the ratio of the probability of a negative test result in a patient with the disease to the probability of a negative test result in a patient without the disease.\n$$LR^{-} = \\frac{P(T^{-}\\mid D^{+})}{P(T^{-}\\mid D^{-})}$$\nThe denominator is the specificity, $S_p$. The numerator, $P(T^{-}\\mid D^{+})$, is the probability of a false negative. Since a patient with the disease can only test positive or negative, we have $P(T^{+}\\mid D^{+}) + P(T^{-}\\mid D^{+}) = 1$. The term $P(T^{+}\\mid D^{+})$ is the sensitivity, $S_e$. Therefore, $P(T^{-}\\mid D^{+}) = 1 - S_e$.\nSubstituting these into the expression for $LR^{-}$ yields:\n$$LR^{-} = \\frac{1 - S_e}{S_p}$$\n\nNow, we compute the numerical values for $LR^{+}$ and $LR^{-}$.\n$$LR^{+} = \\frac{0.88}{1 - 0.82} = \\frac{0.88}{0.18} = 4.888...$$\nRounding to four significant figures, $LR^{+} = 4.889$.\n\n$$LR^{-} = \\frac{1 - 0.88}{0.82} = \\frac{0.12}{0.82} = 0.146341...$$\nRounding to four significant figures, $LR^{-} = 0.1463$.\n\nNext, we use the odds form of Bayes' theorem: $\\text{Post-test odds} = \\text{Pre-test odds} \\times \\text{Likelihood Ratio}$.\nThe pre-test probability is $p_{\\text{pre}} = P(D^{+}) = 0.40$. We convert this to pre-test odds using the formula $\\text{odds} = \\frac{p}{1-p}$.\n$$\\text{Odds}_{\\text{pre}} = \\frac{p_{\\text{pre}}}{1 - p_{\\text{pre}}} = \\frac{0.40}{1 - 0.40} = \\frac{0.40}{0.60} = \\frac{2}{3}$$\n\nFor a positive SPT result, we use $LR^{+}$ to find the post-test odds.\n$$\\text{Odds}_{\\text{post}}^{+} = \\text{Odds}_{\\text{pre}} \\times LR^{+} = \\frac{2}{3} \\times \\frac{0.88}{0.18} = \\frac{2}{3} \\times \\frac{44}{9} = \\frac{88}{27} \\approx 3.259259...$$\nWe then convert these post-test odds back to a probability using the formula $p = \\frac{\\text{odds}}{1+\\text{odds}}$.\n$$p_{\\text{post}}^{+} = P(D^{+}\\mid T^{+}) = \\frac{\\text{Odds}_{\\text{post}}^{+}}{1 + \\text{Odds}_{\\text{post}}^{+}} = \\frac{88/27}{1 + 88/27} = \\frac{88/27}{115/27} = \\frac{88}{115} = 0.765217...$$\nRounding to four significant figures, the post-test probability after a positive SPT is $0.7652$.\n\nFor a negative SPT result, we use $LR^{-}$ to find the post-test odds.\n$$\\text{Odds}_{\\text{post}}^{-} = \\text{Odds}_{\\text{pre}} \\times LR^{-} = \\frac{2}{3} \\times \\frac{0.12}{0.82} = \\frac{2}{3} \\times \\frac{6}{41} = \\frac{4}{41} \\approx 0.0975609...$$\nWe convert these post-test odds back to a probability.\n$$p_{\\text{post}}^{-} = P(D^{+}\\mid T^{-}) = \\frac{\\text{Odds}_{\\text{post}}^{-}}{1 + \\text{Odds}_{\\text{post}}^{-}} = \\frac{4/41}{1 + 4/41} = \\frac{4/41}{45/41} = \\frac{4}{45} = 0.0888...$$\nRounding to four significant figures, the post-test probability after a negative SPT is $0.08889$.\n\nThe four requested numerical values, in order, are:\n1.  $LR^{+} \\approx 4.889$\n2.  $LR^{-} \\approx 0.1463$\n3.  Post-test probability (positive SPT) $\\approx 0.7652$\n4.  Post-test probability (negative SPT) $\\approx 0.08889$", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n4.889 & 0.1463 & 0.7652 & 0.08889\n\\end{pmatrix}\n}\n$$", "id": "5063919"}, {"introduction": "Clinical diagnosis is rarely a single-step process; it is a synthesis of multiple streams of evidence. This final exercise simulates this complex reality, challenging you to integrate information from a patient's history, a skin prick test, and a serum IgE measurement into a single, coherent diagnostic conclusion. By employing a Bayesian framework with combined likelihood ratios [@problem_id:5063863], you will practice the advanced skill of quantitatively synthesizing data to arrive at a robust post-test probability, mirroring the sophisticated reasoning used in challenging clinical cases.", "problem": "An adult patient in an Otorhinolaryngology clinic presents with recurrent rhinoconjunctivitis symptoms that cluster in the grass pollen season. The clinical objective is to estimate the post-test probability of clinically relevant grass pollen allergy to guide discussions about allergen immunotherapy. Use a Bayesian decision framework that integrates three information components: structured history, skin prick testing, and serum allergen-specific immunoglobulin E. The following evidence synthesis from the clinic’s validation studies provides likelihood ratios for each component when positive:\n\n- Structured history indicating strongly seasonal nasal and ocular symptoms consistent with grass pollen exposure has a positive likelihood ratio of $\\text{LR}_{\\text{history}} = 2.8$.\n- Skin prick test to timothy grass (Phleum pratense) is positive by the clinic’s threshold (wheal diameter $\\geq 6 \\text{ mm}$) with $\\text{LR}_{\\text{SPT}} = 5.1$.\n- Serum timothy grass specific immunoglobulin E (measured by a standardized assay) is above the positivity threshold with $\\text{LR}_{\\text{sIgE}} = 3.6$.\n\nAssume conditional independence of these components given the presence or absence of clinical allergy. The prior probability that an adult rhinitis patient in this clinic has clinically relevant grass pollen allergy is $p_{0} = 0.22$.\n\nStarting only from fundamental definitions of likelihood ratios and Bayes’ theorem applied in odds form for sequential diagnostic information, derive the post-test probability of clinically relevant grass pollen allergy for this patient after observing all three positive findings. Express your final answer as a decimal and round your result to four significant figures.", "solution": "The problem is valid. It is scientifically grounded in the principles of Bayesian inference as applied to medical diagnostics, is well-posed with all necessary information provided, and is free of any contradictions or ambiguities.\n\nThe task is to compute the post-test probability of a patient having clinically relevant grass pollen allergy given a set of positive test results. We will use Bayes' theorem in its odds form.\n\nLet $A$ be the event that the patient has a clinically relevant grass pollen allergy. The problem provides the prior probability of this event, which is the prevalence of the condition in the relevant patient population.\n$$p_{0} = P(A) = 0.22$$\nThe complementary event, $A^c$, is that the patient does not have the allergy. Its probability is:\n$$P(A^c) = 1 - P(A) = 1 - 0.22 = 0.78$$\n\nThe odds form of Bayes' theorem requires us to work with odds instead of probabilities. The prior odds in favor of the allergy are defined as the ratio of the probability of having the allergy to the probability of not having it.\n$$\\text{Odds}_{\\text{prior}} = \\frac{P(A)}{P(A^c)} = \\frac{p_{0}}{1-p_{0}}$$\nSubstituting the given value:\n$$\\text{Odds}_{\\text{prior}} = \\frac{0.22}{0.78} = \\frac{22}{78} = \\frac{11}{39}$$\n\nNext, we consider the evidence. We have three pieces of diagnostic information, all of which are positive:\n1.  Structured history ($E_{\\text{history}}$)\n2.  Skin prick test ($E_{\\text{SPT}}$)\n3.  Serum specific immunoglobulin E ($E_{\\text{sIgE}}$)\n\nFor each piece of evidence, we are given the positive likelihood ratio ($\\text{LR}_{+}$). The likelihood ratio is the ratio of the probability of observing the evidence in a patient with the condition to the probability of observing the same evidence in a patient without the condition.\n$$ \\text{LR}_{+} = \\frac{P(\\text{Positive Result} | A)}{P(\\text{Positive Result} | A^c)} $$\nThe given likelihood ratios are:\n$$ \\text{LR}_{\\text{history}} = 2.8 $$\n$$ \\text{LR}_{\\text{SPT}} = 5.1 $$\n$$ \\text{LR}_{\\text{sIgE}} = 3.6 $$\n\nBayes' theorem in odds form states that the post-test odds are the product of the prior odds and the likelihood ratio for the observed evidence:\n$$ \\text{Odds}_{\\text{post}} = \\text{Odds}_{\\text{prior}} \\times \\text{LR} $$\n\nThe problem states that we should assume conditional independence of these three information components. This assumption allows us to calculate the combined likelihood ratio for all three positive findings by multiplying the individual likelihood ratios.\n$$ \\text{LR}_{\\text{total}} = \\text{LR}_{\\text{history}} \\times \\text{LR}_{\\text{SPT}} \\times \\text{LR}_{\\text{sIgE}} $$\nLet's compute this total likelihood ratio:\n$$ \\text{LR}_{\\text{total}} = 2.8 \\times 5.1 \\times 3.6 $$\n$$ \\text{LR}_{\\text{total}} = 14.28 \\times 3.6 = 51.408 $$\n\nNow, we can calculate the post-test odds by updating the prior odds with this total likelihood ratio.\n$$ \\text{Odds}_{\\text{post}} = \\text{Odds}_{\\text{prior}} \\times \\text{LR}_{\\text{total}} $$\n$$ \\text{Odds}_{\\text{post}} = \\frac{11}{39} \\times 51.408 $$\nTo maintain precision, we can express $51.408$ as a fraction: $51.408 = \\frac{51408}{1000} = \\frac{6426}{125}$.\n$$ \\text{Odds}_{\\text{post}} = \\frac{11}{39} \\times \\frac{6426}{125} $$\nWe note that $6426 = 3 \\times 2142$ and $39 = 3 \\times 13$.\n$$ \\text{Odds}_{\\text{post}} = \\frac{11 \\times (3 \\times 2142)}{(3 \\times 13) \\times 125} = \\frac{11 \\times 2142}{13 \\times 125} = \\frac{23562}{1625} $$\nThe decimal value is approximately $14.4996923...$\n\nThe final step is to convert these post-test odds back into a probability. The relationship between probability ($P$) and odds ($O$) is given by:\n$$ P = \\frac{O}{1+O} $$\nTherefore, the post-test probability, $P_{\\text{post}}$, is:\n$$ P_{\\text{post}} = \\frac{\\text{Odds}_{\\text{post}}}{1 + \\text{Odds}_{\\text{post}}} $$\nSubstituting our calculated value for $\\text{Odds}_{\\text{post}}$:\n$$ P_{\\text{post}} = \\frac{\\frac{23562}{1625}}{1 + \\frac{23562}{1625}} = \\frac{\\frac{23562}{1625}}{\\frac{1625 + 23562}{1625}} = \\frac{23562}{25187} $$\n\nNow, we compute the final numerical value and round it to four significant figures as requested.\n$$ P_{\\text{post}} = \\frac{23562}{25187} \\approx 0.93547858 $$\nRounding to four significant figures, we examine the fifth significant digit. The first four are $9$, $3$, $5$, and $4$. The fifth is $7$, which is greater than or equal to $5$, so we round up the fourth digit.\n$$ P_{\\text{post}} \\approx 0.9355 $$\nThis is the estimated post-test probability of clinically relevant grass pollen allergy for the patient.", "answer": "$$\\boxed{0.9355}$$", "id": "5063863"}]}